Literature DB >> 16240433

Influence of powder particle size distribution on complex viscosity and other properties of acrylic bone cement for vertebroplasty and kyphoplasty.

Lidia Hernández1, Mariló Gurruchaga, Isabel Goñi.   

Abstract

For use in vertebroplasty and kyphoplasty, an acrylic bone cement should possess many characteristics, such as high radiopacity, low and constant viscosity during its application, low value of the maximum temperature reached during the polymerization process (T(max)), a setting time (t(set)) that is neither too low nor too high, and high compressive strength. The objective of this study was to investigate the influence of the powder particle distribution on various properties of one acrylic bone cement; namely, residual monomer content, T(max), t(set), complex viscosity, storage and loss moduli, injectability, and quasi-static compressive strength and modulus. It was found that the formulations that possessed the most suitable complex viscosity-versus-mixing time characteristics are those in which the ratio of the large poly(methyl methacrylate) beads (of mean diameter 118.4 microm) to the small ones (of mean diameter 69.7 microm) was at least 90% w/w. For these formulations, the values of the other properties determined were acceptable.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16240433     DOI: 10.1002/jbm.b.30409

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  2 in total

1.  Injectable acrylic bone cements for vertebroplasty based on a radiopaque hydroxyapatite. Formulation and rheological behaviour.

Authors:  L Hernández; M Gurruchaga; I Goñi
Journal:  J Mater Sci Mater Med       Date:  2008-08-14       Impact factor: 3.896

2.  Experimental investigations of the aerated polymethylmethacrylate-based vertebral cement flow in capillaries.

Authors:  Zbigniew Tyfa; Dariusz Witkowski; Krzysztof Sobczak; Damian Obidowski; Krzysztof Jóźwik
Journal:  Int J Artif Organs       Date:  2018-07-18       Impact factor: 1.595

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.